SlideShare uma empresa Scribd logo
1 de 30
Results of the second  Health Care Marketing Survey 2009 Health Care Marketing Congress 0ctober 8 th  2009
Survey participants Scope and numbers Sector ,[object Object],[object Object],Total sample 36% 30% 20% 9% Medical  equipment OTC  Others Number of  respondents  (%) RX 5% Biotech  Total sample European  scope  Worldwide  scope  National  scope  Other 44% 35% 16% 5% Job function 31,8% Marketing Manager Managing Director Product/Brand Manager Communication Manager Other Business Unit Manager Sales Manager Scope of responsibilities Number of  respondents  (%)
Key concept: Net Average Index (NAI) Quantifying Health Care Marketers’ beliefs ,[object Object],[object Object],[object Object],The percentage reflects a balance between the positive, neutral and negative views. It can vary from -100% to +100% depending on the amount of confidence.  A positive NAI indicates an increase of importance, the number reveals how relevant or outspoken this increase is.
True or false? ,[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],True or false?
Today, the Health Care marketer has to take into account the influences of  multiple  stakeholders  Size/stretch of the challenge today (score) Combination of high average and high frequency of occurrence results in 4 main challenges Respondents (%) 1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],2 3 4 5 6 7 9 + + N=93 Ranking of challenges by importance 10 8 - Q: In your opinion, what will be the greatest Health Care related challenges of your division in 2009 -2010?
Compared to last year, the importance of building relationships with hospitals and pharmacists has increased Ranking of the 10 biggest challenges 2010 versus 2008 2009 results 2008 results Respondents (%) N 2008 = 89 N 2009 = 93 LEGEND:
The largest increase in influence and power in the coming year is expected to occur  at  governmental parties Only GP’s will decrease in influence  Evolution of influence/power of different decision makers 43% 43,8% 61% 66% 49% 47% 44% 41% -14,4% Pharmacists Legal and regulatory institutions General practitioners Social security Insurance companies Patient associations Patients Hospitals Specialists N=89 16% 12% 10% 8% -4% 6% Wholesalers & distributors laboratories Research organisations Net Adjusted Index (%) Q: How do you evaluate the influence of the following “decision makers” on your business in the near future?
Key concept: Net Average Index (NAI) Quantifying Health Care Marketers’ beliefs ,[object Object],[object Object],[object Object],The percentage reflects a balance between the positive, neutral and negative views. It can vary from -100% to +100% depending on the amount of confidence.  A positive NAI indicates an increase of importance, the number reveals how relevant or outspoken this increase is.
The largest increase in influence and power in the coming year is expected to occur  at  governmental parties Only GP’s will decrease in influence  Evolution of influence/power of different decision makers 43% 43,8% 61% 66% 49% 47% 44% 41% -14,4% Pharmacists Legal and regulatory institutions General practitioners Social security Insurance companies Patient associations Patients Hospitals Specialists N=89 16% 12% 10% 8% -4% 6% Wholesalers & distributors laboratories Research organisations Net Adjusted Index (%) Q: How do you evaluate the influence of the following “decision makers” on your business in the near future?
Key takeaway n°1 ,[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],True or false?
Competitive differentiation is still the biggest marketing challenge Size/stretch of the challenge today (score) 2 3 5 1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],- + + 4 7 8 6 10 11 12 Combination of high average and high frequency of occurrence  results in 5 main marketing challenges 9 N=89 Ranking of marketing challenges by importance Q: In your opinion, what will be the greatest marketing challenges of your division in 2009-2010?  Respondents (%)
Compared to last year, innovation, measuring ROI and optimizing pricing are the three fastest growing marketing challenges 2009 results 2008 results Ranking of the 5 biggest marketing challenges 2009-10 versus 2008 N 2008 = 89 N 2009 = 90 Respondents (%) LEGEND:
Compared with RX, ME focuses also on price management and ROI, whilst OTC is challenged more by customer loyalty, innovation and MarCom mix Ranking of the 6 biggest marketing challenges 2009-10 by sector RX sector ME sector OTC sector OTC: N= 8 RX: N= 30 ME: N= 28 Note:  ME = Medical Equipment Respondents (%) LEGEND: Top challenges 09-10
Key takeaway n°2 ,[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],True or false?
Health Care marketing budgets in 2008-09 were lower than previously stated and expectations for 2009-10 are even lower Net Adjusted Index (%) 2006 2007 2008 Marketing budgets NAI of marketers from other industries for future budget NAI of Health Care marketers for future budget LEGEND: NAI of Health Care marketer for actual budget 2009 2010 Q: In 2008, how did the total marketing budget available within your marketing department change and what are the expectations for 2009-2010?
Online communication methods and lobbying are expected to replace traditional channels especially during crisis Sponsoring and print are the biggest losers in the expected budget shift Sales visits of specs Sales visits of GP’s Congresses Events and trade fairs Market  research POS materials Above the line media Public relations On-line marketing Direct marketing Sampling Sponsoring Newspapers/magazines Lobbying Patient support groups Price promotions  Average of MarCom budget spent in  2008 (%) NAI, Budget expectations for 2009-10 Budget expectations  for 2009-10 Average  spent in 08  LEGEND: N=66 Evolution of Marketing spending in Health Care Total average  spent in 08
Key takeaway n°3 ,[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],True or false?
The general marketers’ confidence index is at its lowest point in history  Health Care marketers are even more pessimistic Net Adjusted Index(%) 2006 2007 2008 2009 2005 Year General marketers’ confidence index LEGEND: A decrease in their marketing budget will negatively impact the Health Care marketers’ media expenditures and modify  their marketing organization
Marketers believe their pricing will be put under great pressure by governments, patients and pharmacists Government will push cheaper alternatives Pharmacists will protect their margins Patients will become more price sensitive Patients will ask for generic / alternative products Patients will be more critical/pro-actively compare treatments Physicians will change prescription behavior towards cheaper products Loyalty of patients towards a product will decrease Volume of medicines purchased by patients will decrease N=87 Slightly disagree Totally disagree LEGEND: Neutral Slightly agree Fully agree 89% 88% 83% 63% 74% 37% 33% 26% Net Adjusted Index (%) Q: How do you expect customers to react on the current economical crisis?
Key takeaway n°4 ,[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],True or false?
Marketers understand the value that they provide to customers  …  N=90 Q: To what extent do you agree with the following statements? We have a good understanding of the unique value we provide to customers  We can effectively communicate our value  Net Adjusted Index (%) Slightly disagree Totally disagree LEGEND: Neutral Slightly agree Fully agree 82 % 58 %
…  but often  lack the tools to efficiently measure that value  N=90 Q: To what extent do you agree with the following statements? Slightly disagree Totally disagree LEGEND: Neutral Slightly agree Fully agree Management decisions at my company are based on the most recent customer & market data  My company has a detailed marketing and sales dashboard to track evolution of KPI’s  My company leverages the data captured by our CRM system  27 % 26 % 0 % Net Adjusted Index (%)
Key takeaway n°5 ,[object Object]
Key takeaways  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
In collaboration with An initiative by http://www.thom.be/ www.twitter.com/thomeu

Mais conteúdo relacionado

Mais procurados

Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...
Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...
Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...
Eularis
 
2010JanFeb PharmaceuticalMarketingEurope Feature Iftheshoefits
2010JanFeb PharmaceuticalMarketingEurope Feature Iftheshoefits2010JanFeb PharmaceuticalMarketingEurope Feature Iftheshoefits
2010JanFeb PharmaceuticalMarketingEurope Feature Iftheshoefits
Aleksandar Ruzicic
 
Progressions_2011_Final_021011
Progressions_2011_Final_021011Progressions_2011_Final_021011
Progressions_2011_Final_021011
Gautam Jaggi
 

Mais procurados (20)

Medco (MHS) Bench
Medco (MHS) BenchMedco (MHS) Bench
Medco (MHS) Bench
 
Drug value optimization excerpts
Drug value optimization   excerptsDrug value optimization   excerpts
Drug value optimization excerpts
 
Rapport biosimilars excerpts
Rapport biosimilars excerptsRapport biosimilars excerpts
Rapport biosimilars excerpts
 
What is the real value of digital pharma marketing?
What is the real value of digital pharma marketing?What is the real value of digital pharma marketing?
What is the real value of digital pharma marketing?
 
French generics market attractiveness 2017 - 2022 excerpt
French generics market attractiveness   2017 - 2022 excerptFrench generics market attractiveness   2017 - 2022 excerpt
French generics market attractiveness 2017 - 2022 excerpt
 
Generic Pharma 2.0: 10 Potential Industry Game Changers
Generic Pharma 2.0: 10 Potential Industry Game ChangersGeneric Pharma 2.0: 10 Potential Industry Game Changers
Generic Pharma 2.0: 10 Potential Industry Game Changers
 
The future of pharma marketing
The future of pharma marketingThe future of pharma marketing
The future of pharma marketing
 
Amcham Physician Jan15
Amcham Physician Jan15Amcham Physician Jan15
Amcham Physician Jan15
 
Insight_Medtech
Insight_MedtechInsight_Medtech
Insight_Medtech
 
Life Sciences: Leveraging Customer Data for Commercial Success
Life Sciences: Leveraging Customer Data for Commercial SuccessLife Sciences: Leveraging Customer Data for Commercial Success
Life Sciences: Leveraging Customer Data for Commercial Success
 
Mature brand management
Mature brand managementMature brand management
Mature brand management
 
Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...
Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...
Generics Threats And Opportunities: Mounting an Effective Defense Strategy ...
 
2015 Medical Device Outlook - Deloitte
2015 Medical Device Outlook - Deloitte2015 Medical Device Outlook - Deloitte
2015 Medical Device Outlook - Deloitte
 
2010JanFeb PharmaceuticalMarketingEurope Feature Iftheshoefits
2010JanFeb PharmaceuticalMarketingEurope Feature Iftheshoefits2010JanFeb PharmaceuticalMarketingEurope Feature Iftheshoefits
2010JanFeb PharmaceuticalMarketingEurope Feature Iftheshoefits
 
Serialization: Driving Business Value Beyond Compliance
Serialization: Driving Business Value Beyond ComplianceSerialization: Driving Business Value Beyond Compliance
Serialization: Driving Business Value Beyond Compliance
 
Health market trend report 2013
Health market trend report 2013Health market trend report 2013
Health market trend report 2013
 
Pharma's Identity Crisis
Pharma's Identity CrisisPharma's Identity Crisis
Pharma's Identity Crisis
 
Healthcare 2020
Healthcare 2020 Healthcare 2020
Healthcare 2020
 
Progressions_2011_Final_021011
Progressions_2011_Final_021011Progressions_2011_Final_021011
Progressions_2011_Final_021011
 
MCE Survey On New Business Model in Pharmaceuticals
MCE  Survey On New Business Model in PharmaceuticalsMCE  Survey On New Business Model in Pharmaceuticals
MCE Survey On New Business Model in Pharmaceuticals
 

Semelhante a Hc congres 2009 Nicole Berx presentation

Final johnson and johnson revised 1
Final johnson and johnson revised 1Final johnson and johnson revised 1
Final johnson and johnson revised 1
Shekhar Gurnani
 
Pharmaceutical SFE Metrics: Are You Measuring The Wrong Things? (mini)
Pharmaceutical SFE Metrics:  Are You Measuring The Wrong Things?  (mini)Pharmaceutical SFE Metrics:  Are You Measuring The Wrong Things?  (mini)
Pharmaceutical SFE Metrics: Are You Measuring The Wrong Things? (mini)
Eularis
 
ey-pulse-of-the-industry-report
ey-pulse-of-the-industry-reportey-pulse-of-the-industry-report
ey-pulse-of-the-industry-report
Iain Scott
 
Marketing_Services_TLP
Marketing_Services_TLPMarketing_Services_TLP
Marketing_Services_TLP
Marta Rebelo
 
Fox - PharmaVOICE_01-2010
Fox - PharmaVOICE_01-2010Fox - PharmaVOICE_01-2010
Fox - PharmaVOICE_01-2010
Stephen Fox
 
Recruiting Retaining a Competitive Workforce
Recruiting Retaining a Competitive WorkforceRecruiting Retaining a Competitive Workforce
Recruiting Retaining a Competitive Workforce
Mark AJ Smith
 

Semelhante a Hc congres 2009 Nicole Berx presentation (20)

Final johnson and johnson revised 1
Final johnson and johnson revised 1Final johnson and johnson revised 1
Final johnson and johnson revised 1
 
Adherence product plan v6.1
Adherence product plan v6.1Adherence product plan v6.1
Adherence product plan v6.1
 
Pharmaceutical Lifecycle Management Challenges - Slides from Pharmaceutical P...
Pharmaceutical Lifecycle Management Challenges - Slides from Pharmaceutical P...Pharmaceutical Lifecycle Management Challenges - Slides from Pharmaceutical P...
Pharmaceutical Lifecycle Management Challenges - Slides from Pharmaceutical P...
 
Pharmaceutical SFE Metrics: Are You Measuring The Wrong Things? (mini)
Pharmaceutical SFE Metrics:  Are You Measuring The Wrong Things?  (mini)Pharmaceutical SFE Metrics:  Are You Measuring The Wrong Things?  (mini)
Pharmaceutical SFE Metrics: Are You Measuring The Wrong Things? (mini)
 
Towards Value Innovation In Pharma SFE Conference London 062007
Towards Value Innovation In Pharma SFE Conference London 062007Towards Value Innovation In Pharma SFE Conference London 062007
Towards Value Innovation In Pharma SFE Conference London 062007
 
Value Innovation To Pharma - What Changes To Busisness, Zurich 2008
Value Innovation To Pharma - What Changes To Busisness, Zurich 2008Value Innovation To Pharma - What Changes To Busisness, Zurich 2008
Value Innovation To Pharma - What Changes To Busisness, Zurich 2008
 
ey-pulse-of-the-industry-report
ey-pulse-of-the-industry-reportey-pulse-of-the-industry-report
ey-pulse-of-the-industry-report
 
The CMO Survey - Highlights and Insights Report - September 2022
The CMO Survey - Highlights and Insights Report - September 2022 The CMO Survey - Highlights and Insights Report - September 2022
The CMO Survey - Highlights and Insights Report - September 2022
 
Pharma Market Research Report Dec 2013
Pharma Market Research Report Dec 2013Pharma Market Research Report Dec 2013
Pharma Market Research Report Dec 2013
 
Pharma Industry Trends in 2015
Pharma Industry Trends in 2015Pharma Industry Trends in 2015
Pharma Industry Trends in 2015
 
Marketing_Services_TLP
Marketing_Services_TLPMarketing_Services_TLP
Marketing_Services_TLP
 
Johnson and Johnson Case Competition RU Team J
Johnson and Johnson Case Competition RU Team JJohnson and Johnson Case Competition RU Team J
Johnson and Johnson Case Competition RU Team J
 
White Paper: Best Practices for Medical Benefit Management (MBM)
White Paper: Best Practices for Medical Benefit Management (MBM)White Paper: Best Practices for Medical Benefit Management (MBM)
White Paper: Best Practices for Medical Benefit Management (MBM)
 
Leading the Customer Experience in Healthcare and Life Science
Leading the Customer Experience in Healthcare and Life ScienceLeading the Customer Experience in Healthcare and Life Science
Leading the Customer Experience in Healthcare and Life Science
 
Where does pharma marketing go from here
Where does pharma marketing go from hereWhere does pharma marketing go from here
Where does pharma marketing go from here
 
Digital marketing a new dimension in pharmaceutical field
Digital marketing   a new dimension in pharmaceutical fieldDigital marketing   a new dimension in pharmaceutical field
Digital marketing a new dimension in pharmaceutical field
 
Fox - PharmaVOICE_01-2010
Fox - PharmaVOICE_01-2010Fox - PharmaVOICE_01-2010
Fox - PharmaVOICE_01-2010
 
A shock to the system
A shock to the systemA shock to the system
A shock to the system
 
Business Environment.ppt
Business Environment.pptBusiness Environment.ppt
Business Environment.ppt
 
Recruiting Retaining a Competitive Workforce
Recruiting Retaining a Competitive WorkforceRecruiting Retaining a Competitive Workforce
Recruiting Retaining a Competitive Workforce
 

Mais de The House of Marketing

Discover The House of Marketing as your future employer
Discover The House of Marketing as your future employerDiscover The House of Marketing as your future employer
Discover The House of Marketing as your future employer
The House of Marketing
 

Mais de The House of Marketing (20)

The House of Marketing as your future employer
The House of Marketing as your future employerThe House of Marketing as your future employer
The House of Marketing as your future employer
 
Why "purpose" should be on every organization's priority list
Why "purpose" should be on every organization's priority listWhy "purpose" should be on every organization's priority list
Why "purpose" should be on every organization's priority list
 
12 tools to boost your company's innovation skills
12 tools to boost your company's innovation skills12 tools to boost your company's innovation skills
12 tools to boost your company's innovation skills
 
The innovation kickstart toolkit
The innovation kickstart toolkitThe innovation kickstart toolkit
The innovation kickstart toolkit
 
The toolbox of a digital marketer
The toolbox of a digital marketerThe toolbox of a digital marketer
The toolbox of a digital marketer
 
Marketing automation does not happen automatically
Marketing automation does not happen automaticallyMarketing automation does not happen automatically
Marketing automation does not happen automatically
 
10 Trends every marketer should know for 2018
10 Trends every marketer should know for 201810 Trends every marketer should know for 2018
10 Trends every marketer should know for 2018
 
Tips and tricks to write a good pov
Tips and tricks to write a good povTips and tricks to write a good pov
Tips and tricks to write a good pov
 
What we’ll remember from the 2017 Web Summit
What we’ll remember from the 2017 Web SummitWhat we’ll remember from the 2017 Web Summit
What we’ll remember from the 2017 Web Summit
 
Discover the house of marketing as your future employer 2017
Discover the house of marketing as your future employer 2017Discover the house of marketing as your future employer 2017
Discover the house of marketing as your future employer 2017
 
How to test before sending emails in a marketing automation platform
How to test before sending emails in a marketing automation platformHow to test before sending emails in a marketing automation platform
How to test before sending emails in a marketing automation platform
 
Customer experience, a competitive advantage?
Customer experience, a competitive advantage?Customer experience, a competitive advantage?
Customer experience, a competitive advantage?
 
e-tradesummit 2016
e-tradesummit 2016e-tradesummit 2016
e-tradesummit 2016
 
Immersion camp compilation 2016
Immersion camp compilation 2016Immersion camp compilation 2016
Immersion camp compilation 2016
 
THoMster class brussels - marketing of the future
THoMster class brussels - marketing of the futureTHoMster class brussels - marketing of the future
THoMster class brussels - marketing of the future
 
Discover The House of Marketing as your future employer
Discover The House of Marketing as your future employerDiscover The House of Marketing as your future employer
Discover The House of Marketing as your future employer
 
THoMster class antwerp - branding & positioning
THoMster class antwerp - branding & positioningTHoMster class antwerp - branding & positioning
THoMster class antwerp - branding & positioning
 
HACKATHOM by The House of Marketing
HACKATHOM by The House of MarketingHACKATHOM by The House of Marketing
HACKATHOM by The House of Marketing
 
Millennials: the marketing environment for the new generation of shoppers
Millennials: the marketing environment for the new generation of shoppersMillennials: the marketing environment for the new generation of shoppers
Millennials: the marketing environment for the new generation of shoppers
 
Best advices from bernard gustin on how to turn a crisis into an opportunity
Best advices from bernard gustin on how to turn a crisis into an opportunityBest advices from bernard gustin on how to turn a crisis into an opportunity
Best advices from bernard gustin on how to turn a crisis into an opportunity
 

Hc congres 2009 Nicole Berx presentation

  • 1. Results of the second Health Care Marketing Survey 2009 Health Care Marketing Congress 0ctober 8 th 2009
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7. Compared to last year, the importance of building relationships with hospitals and pharmacists has increased Ranking of the 10 biggest challenges 2010 versus 2008 2009 results 2008 results Respondents (%) N 2008 = 89 N 2009 = 93 LEGEND:
  • 8. The largest increase in influence and power in the coming year is expected to occur at governmental parties Only GP’s will decrease in influence Evolution of influence/power of different decision makers 43% 43,8% 61% 66% 49% 47% 44% 41% -14,4% Pharmacists Legal and regulatory institutions General practitioners Social security Insurance companies Patient associations Patients Hospitals Specialists N=89 16% 12% 10% 8% -4% 6% Wholesalers & distributors laboratories Research organisations Net Adjusted Index (%) Q: How do you evaluate the influence of the following “decision makers” on your business in the near future?
  • 9.
  • 10. The largest increase in influence and power in the coming year is expected to occur at governmental parties Only GP’s will decrease in influence Evolution of influence/power of different decision makers 43% 43,8% 61% 66% 49% 47% 44% 41% -14,4% Pharmacists Legal and regulatory institutions General practitioners Social security Insurance companies Patient associations Patients Hospitals Specialists N=89 16% 12% 10% 8% -4% 6% Wholesalers & distributors laboratories Research organisations Net Adjusted Index (%) Q: How do you evaluate the influence of the following “decision makers” on your business in the near future?
  • 11.
  • 12.
  • 13.
  • 14. Compared to last year, innovation, measuring ROI and optimizing pricing are the three fastest growing marketing challenges 2009 results 2008 results Ranking of the 5 biggest marketing challenges 2009-10 versus 2008 N 2008 = 89 N 2009 = 90 Respondents (%) LEGEND:
  • 15. Compared with RX, ME focuses also on price management and ROI, whilst OTC is challenged more by customer loyalty, innovation and MarCom mix Ranking of the 6 biggest marketing challenges 2009-10 by sector RX sector ME sector OTC sector OTC: N= 8 RX: N= 30 ME: N= 28 Note: ME = Medical Equipment Respondents (%) LEGEND: Top challenges 09-10
  • 16.
  • 17.
  • 18. Health Care marketing budgets in 2008-09 were lower than previously stated and expectations for 2009-10 are even lower Net Adjusted Index (%) 2006 2007 2008 Marketing budgets NAI of marketers from other industries for future budget NAI of Health Care marketers for future budget LEGEND: NAI of Health Care marketer for actual budget 2009 2010 Q: In 2008, how did the total marketing budget available within your marketing department change and what are the expectations for 2009-2010?
  • 19. Online communication methods and lobbying are expected to replace traditional channels especially during crisis Sponsoring and print are the biggest losers in the expected budget shift Sales visits of specs Sales visits of GP’s Congresses Events and trade fairs Market research POS materials Above the line media Public relations On-line marketing Direct marketing Sampling Sponsoring Newspapers/magazines Lobbying Patient support groups Price promotions Average of MarCom budget spent in 2008 (%) NAI, Budget expectations for 2009-10 Budget expectations for 2009-10 Average spent in 08 LEGEND: N=66 Evolution of Marketing spending in Health Care Total average spent in 08
  • 20.
  • 21.
  • 22. The general marketers’ confidence index is at its lowest point in history Health Care marketers are even more pessimistic Net Adjusted Index(%) 2006 2007 2008 2009 2005 Year General marketers’ confidence index LEGEND: A decrease in their marketing budget will negatively impact the Health Care marketers’ media expenditures and modify their marketing organization
  • 23. Marketers believe their pricing will be put under great pressure by governments, patients and pharmacists Government will push cheaper alternatives Pharmacists will protect their margins Patients will become more price sensitive Patients will ask for generic / alternative products Patients will be more critical/pro-actively compare treatments Physicians will change prescription behavior towards cheaper products Loyalty of patients towards a product will decrease Volume of medicines purchased by patients will decrease N=87 Slightly disagree Totally disagree LEGEND: Neutral Slightly agree Fully agree 89% 88% 83% 63% 74% 37% 33% 26% Net Adjusted Index (%) Q: How do you expect customers to react on the current economical crisis?
  • 24.
  • 25.
  • 26. Marketers understand the value that they provide to customers … N=90 Q: To what extent do you agree with the following statements? We have a good understanding of the unique value we provide to customers We can effectively communicate our value Net Adjusted Index (%) Slightly disagree Totally disagree LEGEND: Neutral Slightly agree Fully agree 82 % 58 %
  • 27. … but often lack the tools to efficiently measure that value N=90 Q: To what extent do you agree with the following statements? Slightly disagree Totally disagree LEGEND: Neutral Slightly agree Fully agree Management decisions at my company are based on the most recent customer & market data My company has a detailed marketing and sales dashboard to track evolution of KPI’s My company leverages the data captured by our CRM system 27 % 26 % 0 % Net Adjusted Index (%)
  • 28.
  • 29.
  • 30. In collaboration with An initiative by http://www.thom.be/ www.twitter.com/thomeu

Notas do Editor

  1. (184 participants, 51% completed the whole survey) 28% of the participants are Marketing Managers Other= Pricing manager, market researcher, business analyst 36% work in the RX-business, 30% in the Medical equipment RX: medication requiring prescriptions OTC: “over the counter” 15% of total turnover of 5 biggest European healthcare companies Others: research, hospitals Spread of answers: RX= 57 answered only profile questions, about 33 answered the whole survey ME= 47 – 28 Others= 48 - 18 OTC= 18 - 8 Biotech= 14 - 6 44% have a national scope, 51% an international scope of responsibilities
  2. (184 participants, 51% completed the whole survey) 28% of the participants are Marketing Managers Other= Pricing manager, market researcher, business analyst 36% work in the RX-business, 30% in the Medical equipment RX: medication requiring prescriptions OTC: “over the counter” 15% of total turnover of 5 biggest European healthcare companies Others: research, hospitals Spread of answers: RX= 57 answered only profile questions, about 33 answered the whole survey ME= 47 – 28 Others= 48 - 18 OTC= 18 - 8 Biotech= 14 - 6 44% have a national scope, 51% an international scope of responsibilities
  3. Average score: the higher, the bigger the challenge
  4. On the other hand, dealing with decrease of reimbursement, increasing innovation cost and higher regulatory requirements have decreased in importance
  5. (184 participants, 51% completed the whole survey) 28% of the participants are Marketing Managers Other= Pricing manager, market researcher, business analyst 36% work in the RX-business, 30% in the Medical equipment RX: medication requiring prescriptions OTC: “over the counter” 15% of total turnover of 5 biggest European healthcare companies Others: research, hospitals Spread of answers: RX= 57 answered only profile questions, about 33 answered the whole survey ME= 47 – 28 Others= 48 - 18 OTC= 18 - 8 Biotech= 14 - 6 44% have a national scope, 51% an international scope of responsibilities
  6. Differentiating from competition remains the top marketing challenge
  7. Health Care marketers are even less confident than in other industries The marketers confidence index is an average of marketers’ expectations about their budget, projects and staff headcount. The percentage reflects a balance between the positive, neutral and negative views. It can vary from -100% to +100% depending on the amount of confidence.